Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Overview

Save information for later
Sign Up

Learn About Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)

What is the definition of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)?
Gastroenteropancreatic neuroendocrine tumor (GEP-NET), also known as carcinoid tumor or islet cell tumor, is a rare disease of cells that control hormones and nerves. Gastroenteropancreatic neuroendocrine tumors most frequently occur in the esophagus, pancreas, stomach, small intestine, colon, rectum, or appendix and can be benign or cancerous. Malignant (cancerous) gastroenteropancreatic neuroendocrine tumors can spread to other parts of the body, such as the lymph nodes, lungs, liver, and bones.
What are the symptoms of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)?
Some individuals with gastroenteropancreatic neuroendocrine tumor may not experience any symptoms. Symptoms of gastroenteropancreatic neuroendocrine tumor may include unexplained weight loss; loss of appetite; nausea; yellowing of the skin, whites of eyes, and mucous membranes (jaundice); facial flushing; and severe diarrhea or gastrointestinal bleeding.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)?
Treatment for a gastroenteropancreatic neuroendocrine tumor that is fast-growing or has spread usually involves surgery to remove the tumor and medications to slow tumor growth, such as octreotide, lanreotide, and telotristat; targeted therapies, such as everolimus and sunitinib; chemotherapy; and peptide receptor radiotherapy (Lu 177 or Lutathera). In individuals with a slow-growing gastroenteropancreatic neuroendocrine tumor, a wait and watch strategy may be followed before deciding on surgery.
Who are the top Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Local Doctors?
Experienced in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Hematology Oncology | Hematology | Oncology
Experienced in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Hematology Oncology | Hematology | Oncology

Carris Health LLC

301 Becker Ave Sw, 
Willmar, MN 
 (13.4 mi)
Languages Spoken:
English, Russian, Spanish
Accepting New Patients
Offers Telehealth

Anna Perelshteyn is a Hematologist Oncology specialist and a Hematologist in Willmar, Minnesota. Dr. Perelshteyn and is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Her top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Large-Cell Immunoblastic Lymphoma, and Familial Colorectal Cancer. Dr. Perelshteyn is currently accepting new patients.

Experienced in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Hematology Oncology | Oncology | Hematology
Experienced in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Hematology Oncology | Oncology | Hematology

Carris Health LLC

301 Becker Ave Sw, 
Willmar, MN 
 (13.4 mi)
Languages Spoken:
English
Accepting New Patients

Dennis Buck is a Hematologist Oncology specialist and an Oncologist in Willmar, Minnesota. Dr. Buck and is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Paget Disease of the Breast, Familial Colorectal Cancer, and Inflammatory Breast Cancer. Dr. Buck is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Oncology | Hematology | Hematology Oncology
Experienced in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Oncology | Hematology | Hematology Oncology

Carris Health LLC

301 Becker Ave Sw, 
Willmar, MN 
 (13.4 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

John Tate is an Oncologist and a Hematologist in Willmar, Minnesota. Dr. Tate and is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Lung Cancer. Dr. Tate is currently accepting new patients.

What are the latest Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started